Euronext Corporate Services

BIOTECH BAROMETER H1 2020

Twice a year Euronext and BiotechBourse publish a Biotech Barometer to showcase the trends and key figures of the biotech companies listed on the Euronext markets. Download the H1 2020 edition to discover performance indicators, the evolution of investor interest and market sentiment. Given the unique situation in the first half of 2020, we also looked into the COVID-19 impact on biotech financing and growth.

Get access to the Biotech Barometer H1 2020

KEY INSIGHTS OF THE REPORT
Biotech barometer H12020-2
52118_BioTech-Barometer-COVID-H1-2020_video
biotech barometer H1 2020-1

About Post-Listing Advisory

The Biotech Barometer H1 2020 was created by the Euronext Corporate Services Post-Listing Advisory team, in collaboration with BiotechBourse. Providing value-added services to issuers since 2015, our team of advisors assists senior management at listed SMEs, providing advisory and decision-making analytics to deliver on their strategic ambition in the capital markets.

Euronext Post-Listing Advisory offers a full range of services and a dedicated team to support your annual listing roadmap:

  • Annual ‘360° listing diagnostic’
  • Preparation and feedback memos
  • Board reports
  • Weekly market updates
  • Analysts’ consensus updates
  • Institutional data alerts
barometre

Get access to the report 

 

TAKE ME TO THE TOP

 

Follow us on LinkedIn

linkedin-1

Euronext Corporate Services B.V. is incorporated under the laws of The Netherlands (Chamber of Commerce in Amsterdam under Registration no 68034970), having its registered office at Beursplein 5 (1012 JW) Amsterdam, The Netherlands. Euronext Corporate Services B.V. is part of the Euronext Group and a fully-owned subsidiary of Euronext N.V.